{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:51:39Z","timestamp":1764996699682},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1016\/s0167-8140(02)00106-8","type":"journal-article","created":{"date-parts":[[2002,10,15]],"date-time":"2002-10-15T01:22:28Z","timestamp":1034644948000},"page":"329-338","source":"Crossref","is-referenced-by-count":27,"title":["Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro"],"prefix":"10.1016","volume":"63","author":[{"given":"Vincent","family":"Gr\u00e9goire","sequence":"first","affiliation":[]},{"given":"Jean-Fran\u00e7ois","family":"Rosier","sequence":"additional","affiliation":[]},{"given":"Marc","family":"De Bast","sequence":"additional","affiliation":[]},{"given":"Monique","family":"Bruniaux","sequence":"additional","affiliation":[]},{"given":"Blanche","family":"De Coster","sequence":"additional","affiliation":[]},{"given":"Michelle","family":"Octave-Prignot","sequence":"additional","affiliation":[]},{"given":"Pierre","family":"Scalliet","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0167-8140(02)00106-8_BIB1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00002820-199904000-00011","article-title":"Gemcitabine: a pharmacologic and clinical overview","volume":"22","author":"Barton-Burke","year":"1999","journal-title":"Cancer Nurs"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0006-2952(98)00318-9","article-title":"Decreased resistance to gemcitabine (2\u2032,2\u2032-difluorodeoxycytidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase","volume":"57","author":"Bergman","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB3","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0006-2952(93)90444-2","article-title":"Kinetic studies on 2\u2032,2\u2032-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase","volume":"45","author":"Bouffard","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0145-2126(95)00067-4","article-title":"Comparison of the induction of apoptosis in human leukemic cell lines by 2\u2032,2\u2032-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside","volume":"19","author":"Bouffard","year":"1995","journal-title":"Leuk Res"},{"issue":"Suppl 3","key":"10.1016\/S0167-8140(02)00106-8_BIB5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.1998.750","article-title":"The role of gemcitabine in the treatment of other tumours","volume":"78","author":"Carmichael","year":"1998","journal-title":"Br J Cancer"},{"issue":"Suppl 4","key":"10.1016\/S0167-8140(02)00106-8_BIB6","first-page":"20","article-title":"Combination chemoradiotherapy with gemcitabine: potential applications","volume":"14","author":"Choy","year":"2000","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-2952(00)00534-7","article-title":"Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes","volume":"61","author":"Csapo","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB8","series-title":"Nonionic detergent for isolation of cytoplasmic (and nuclear) RNA","first-page":"329","author":"Davis","year":"1994"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.2001.19.3.792","article-title":"Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study","volume":"19","author":"Eisbruch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/bjc.1997.554","article-title":"Kinetics of mouse jejunum radiosensitization by 2\u2032-2\u2032 difluorodeoxycytidine (Gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells","volume":"76","author":"Gregoire","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/095530098142059","article-title":"Radiosensitization of mouse sarcoma cells by Fludarabine or Gemcitabine, two nucleoside analogs, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis","volume":"73","author":"Gregoire","year":"1998","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2307\/3580214","article-title":"Effect of Gemcitabine (dFdC) on the tolerance of the lung to single dose irradiation in C3H mice","volume":"151","author":"Gregoire","year":"1999","journal-title":"Radiat Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB13","first-page":"949","article-title":"Chemo-radiotherapy: radiosensitizing nucleoside analogues (review)","volume":"6","author":"Gregoire","year":"1999","journal-title":"Oncol Rep"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/stem.140351","article-title":"2\u2032,2\u2032-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA)","volume":"14","author":"Gruber","year":"1996","journal-title":"Stem Cells"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.1992.10.3.406","article-title":"Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study","volume":"10","author":"Grunewald","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB16","first-page":"2343","article-title":"Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity","volume":"56","author":"Hapke","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB17","first-page":"533","article-title":"Cellular elimination of 2\u2032,2\u2032-difluorodeoxycytidine 5\u2032-triphosphate: a mechanism of self-potentiation","volume":"52","author":"Heinemann","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(93)80116-C","article-title":"Cell cycle regulation of deoxycytidine kinase. Evidence for post-transcriptional control","volume":"321","author":"Hengstschlager","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB19","first-page":"2816","article-title":"Distribution of kinase and deaminase of 1-beta-d-arabinofuranosylcytosine in tissues of man and mouse","volume":"33","author":"Ho","year":"1973","journal-title":"Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0003-2697(92)90518-C","article-title":"A quantitative assay for fragmented DNA in apoptotic cells","volume":"207","author":"Huang","year":"1992","journal-title":"Anal Biochem"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB21","first-page":"115","article-title":"Transcient inhibition of chromosome damage repair after ionizing radiation by gemcitabine (Abstract)","volume":"36","author":"Huang","year":"1995","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1520-6823(1997)5:2<62::AID-ROI4>3.0.CO;2-H","article-title":"Enhancement of radiation-induced regrowth delay by Gemcitabine in a human tumor xenograft model","volume":"5","author":"Joschko","year":"1997","journal-title":"Radiat Oncol Invest"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0360-3016(98)00105-9","article-title":"Radiosensitizing potential of Gemcitabine within the cell cycle in vitro","volume":"41","author":"Latz","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB24","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0360-3016(95)02134-5","article-title":"Radiosensitization of pancreatic cancer cells by 2\u2032-2\u2032 difluorodeoxycytidine","volume":"41","author":"Lawrence","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB25","first-page":"777","article-title":"Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2\u2032-2\u2032 difluorodeoxycytidine (Gemcitabine)","volume":"3","author":"Lawrence","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0596-567","article-title":"Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo","volume":"5","author":"Manome","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0360-3016(99)00134-0","article-title":"Maximizing therapeutic gain with gemcitabine and fractionated radiation","volume":"44","author":"Mason","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3574512","article-title":"A parametric method for estimation of dose-modifying factors: low-dose extrapolation limit","volume":"69","author":"McLarty","year":"1977","journal-title":"Radiat Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB29","first-page":"107","article-title":"Enhancement of tumor radioresponse in vivo by Gemcitabine","volume":"59","author":"Milas","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB30","first-page":"102","article-title":"Cytotoxicity and radiosensitization of Gemcitabine in human glioblastoma cell lines (Abstract)","volume":"38","author":"Ostruszka","year":"1997","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB31","first-page":"2389","article-title":"Resistance to 1-beta-d-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene","volume":"52","author":"Owens","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/13543784.5.6.637","article-title":"New antimetabolites in preclinical and clinical development","volume":"5","author":"Peters","year":"1996","journal-title":"Exp Opin Invest Drugs"},{"issue":"Suppl 6","key":"10.1016\/S0167-8140(02)00106-8_BIB33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001813-199512006-00002","article-title":"Preclinical characteristics of gemcitabine","volume":"6","author":"Plunkett","year":"1995","journal-title":"Anticancer Drugs"},{"issue":"Suppl 11","key":"10.1016\/S0167-8140(02)00106-8_BIB34","first-page":"3","article-title":"Gemcitabine: metabolism, mechanisms of action, and self-potentiation","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB35","first-page":"1585","article-title":"End-joining deficiency and radiosensitization induced by gemcitabine","volume":"61","author":"van Putten","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB36","first-page":"151","article-title":"Effect of 2\u2032-2\u2032 difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro","volume":"4","author":"Rockwell","year":"1992","journal-title":"Oncol Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB37","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0959-8049(97)84477-2","article-title":"The role of Gemcitabine-induced cell cycle synchronization in radiosensitization of a SCC61 human head and neck squamous carcinoma cell line (Abstract)","volume":"33","author":"Rosier","year":"1997","journal-title":"Proc Eur Cancer Conf"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/095530099140708","article-title":"The effect of 2\u2032-2\u2032 difluorodeoxycytidine (dFdC, Gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity","volume":"75","author":"Rosier","year":"1999","journal-title":"Int J Radiat Biol"},{"issue":"Suppl 1","key":"10.1016\/S0167-8140(02)00106-8_BIB39","first-page":"S114","article-title":"Intracellular metabolism of dFdC (gemcitabine) as a mechanism of radioenhancement in two human head and neck squamous cell carcinoma cell lines","volume":"56","author":"Rosier","year":"2000","journal-title":"Radiother Oncol"},{"issue":"Suppl 1","key":"10.1016\/S0167-8140(02)00106-8_BIB40","first-page":"S184","article-title":"Repair inhibition of radation-induced chromosome aberrations but not DNA DSBs is involved in gemcitabines's (dFdC) radio-emhancement","volume":"48","author":"Rosier","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB41","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/0959-8049(93)90048-K","article-title":"Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts","volume":"29A","author":"Ruiz van Haperen","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0006-2952(93)90566-F","article-title":"2\u2032,2\u2032-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines","volume":"46","author":"Ruiz van Haperen","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0006-2952(94)90554-1","article-title":"Schedule dependence of sensitivity to 2\u2032,2\u2032-Difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours","volume":"48","author":"Ruiz Van Happeren","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB44","first-page":"4138","article-title":"Development and molecular characterization of a 2\u2032,2\u2032-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780","volume":"54","author":"Ruiz van Haperen","year":"1994","journal-title":"Cancer Res"},{"issue":"Suppl 11","key":"10.1016\/S0167-8140(02)00106-8_BIB45","first-page":"35","article-title":"Induction of resistance to 2\u2032,2\u2032-difluorodeoxycytidine in the human ovarian cancer cell line A2780","volume":"4","author":"Ruiz van Haperen","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB46","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0006-2952(95)02402-6","article-title":"Regulation of phosphorylation of deoxycytidine and 2\u2032,2\u2032-difluorodeoxycytidine (gemcitabine); effects of cytidine 5\u2032-triphosphate and uridine 5\u2032-triphosphate in relation to chemosensitivity for 2\u2032,2\u2032-difluorodeoxycytidine","volume":"51","author":"Ruis van Haperen","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB47","first-page":"3218","article-title":"Metabolism of 2\u2032-2\u2032 difluorodeoxycytidine and radiation sensitization of human colon carcinoma cells","volume":"54","author":"Shewach","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB48","first-page":"68","article-title":"Radiosensitization of human tumor cells by Gemcitabine in vitro","volume":"22","author":"Shewach","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0959-8049(94)00435-8","article-title":"Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues","volume":"31A","author":"Spasokoukotskaja","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF01696231","article-title":"In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2\u2032-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene","volume":"71","author":"Stegmann","year":"1995","journal-title":"Ann Hematol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB51","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood.V85.5.1188.bloodjournal8551188","article-title":"Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity","volume":"85","author":"Stegmann","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB52","doi-asserted-by":"crossref","first-page":"22847","DOI":"10.1016\/S0021-9258(18)41605-5","article-title":"Substrate specificity of mitochondrial 2\u2032-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine","volume":"268","author":"Wang","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB53","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/095530099139764","article-title":"Radiation-induced changes in nucleotide metabolism of two colon cancer cell lines with different radiosensitivities","volume":"75","author":"Wei","year":"1999","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/S0167-8140(02)00106-8_BIB54","first-page":"2246","article-title":"Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma","volume":"7","author":"Wolff","year":"2001","journal-title":"Clin Cancer Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814002001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814002001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:39:24Z","timestamp":1622245164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814002001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0167814002001068"],"URL":"https:\/\/doi.org\/10.1016\/s0167-8140(02)00106-8","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}